ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3: In Vitro to In Vivo: Modeling Life in 3D

Research output: Contribution to journalConference articleResearchpeer-review

Standard

ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3 : In Vitro to In Vivo: Modeling Life in 3D. / Di Mauro, Gianmarco; Dondi, Ambra; Giangreco, Giovanni; Hogrebe, Alexander; Louer, Elja; Magistrati, Elisa; Mullari, Meeli; Turon, Gemma; Verdurmen, Wouter; Cortada, Helena Xicoy; Zivanovic, Sanja.

In: Journal of Personalized Medicine, Vol. 8, No. 2, 20, 2018, p. 1-5.

Research output: Contribution to journalConference articleResearchpeer-review

Harvard

Di Mauro, G, Dondi, A, Giangreco, G, Hogrebe, A, Louer, E, Magistrati, E, Mullari, M, Turon, G, Verdurmen, W, Cortada, HX & Zivanovic, S 2018, 'ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3: In Vitro to In Vivo: Modeling Life in 3D', Journal of Personalized Medicine, vol. 8, no. 2, 20, pp. 1-5. https://doi.org/10.3390/jpm8020020

APA

Di Mauro, G., Dondi, A., Giangreco, G., Hogrebe, A., Louer, E., Magistrati, E., Mullari, M., Turon, G., Verdurmen, W., Cortada, H. X., & Zivanovic, S. (2018). ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3: In Vitro to In Vivo: Modeling Life in 3D. Journal of Personalized Medicine, 8(2), 1-5. [20]. https://doi.org/10.3390/jpm8020020

Vancouver

Di Mauro G, Dondi A, Giangreco G, Hogrebe A, Louer E, Magistrati E et al. ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3: In Vitro to In Vivo: Modeling Life in 3D. Journal of Personalized Medicine. 2018;8(2):1-5. 20. https://doi.org/10.3390/jpm8020020

Author

Di Mauro, Gianmarco ; Dondi, Ambra ; Giangreco, Giovanni ; Hogrebe, Alexander ; Louer, Elja ; Magistrati, Elisa ; Mullari, Meeli ; Turon, Gemma ; Verdurmen, Wouter ; Cortada, Helena Xicoy ; Zivanovic, Sanja. / ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3 : In Vitro to In Vivo: Modeling Life in 3D. In: Journal of Personalized Medicine. 2018 ; Vol. 8, No. 2. pp. 1-5.

Bibtex

@inproceedings{3892ea39b0294e2e91dabf056969d509,
title = "ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3: In Vitro to In Vivo: Modeling Life in 3D",
abstract = "The EUROPEAN ACADEMY FOR BIOMEDICAL SCIENCE (ENABLE) is an initiative funded by the European Union Horizon 2020 program involving four renowned European research institutes (Institute for Research in Biomedicine-IRB Barcelona, Spain; Radboud Institute for Molecular Life Sciences-RIMLS, the Netherlands; Novo Nordisk Foundation Center for Protein Research-NNF CPR, Denmark; European School of Molecular Medicine-SEMM, Italy) and an innovative science communication agency (Scienseed). With the aim to promote biomedical science of excellence in Europe, ENABLE organizes an annual three-day international event. This gathering includes a top-level scientific symposium bringing together leading scientists, PhD students, and post-doctoral fellows; career development activities supporting the progression of young researchers and fostering discussion about opportunities beyond the bench; outreach activities stimulating the interaction between science and society. The first European PhD and Postdoc Symposium, entitled {"}Breaking Down Complexity: Innovative models and techniques in biomedicine{"}, was hosted by the vibrant city of Barcelona. The scientific program of the conference was focused on the most recent advances and applications of modern techniques and models in biomedical research and covered a wide range of topics, from synthetic biology to translational medicine. Overall, the event was a great success, with more than 200 attendees from all over Europe actively participating in the symposium by presenting their research and exchanging ideas with their peers and world-renowned scientists.",
keywords = "Biomedicine, Cancer, Diabetes, Leukemia, Stem cells, Symposium",
author = "{Di Mauro}, Gianmarco and Ambra Dondi and Giovanni Giangreco and Alexander Hogrebe and Elja Louer and Elisa Magistrati and Meeli Mullari and Gemma Turon and Wouter Verdurmen and Cortada, {Helena Xicoy} and Sanja Zivanovic",
note = "Conference Report; ENABLE 2017 : the First EUROPEAN PhD and Post-Doc Symposium ; Conference date: 15-11-2017 Through 17-11-2017",
year = "2018",
doi = "10.3390/jpm8020020",
language = "English",
volume = "8",
pages = "1--5",
journal = "Journal of Personalized Medicine",
issn = "2075-4426",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",
url = "https://www.irbbarcelona.org/en/events/enable-conference",

}

RIS

TY - GEN

T1 - ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3

T2 - ENABLE 2017

AU - Di Mauro, Gianmarco

AU - Dondi, Ambra

AU - Giangreco, Giovanni

AU - Hogrebe, Alexander

AU - Louer, Elja

AU - Magistrati, Elisa

AU - Mullari, Meeli

AU - Turon, Gemma

AU - Verdurmen, Wouter

AU - Cortada, Helena Xicoy

AU - Zivanovic, Sanja

N1 - Conference code: 1

PY - 2018

Y1 - 2018

N2 - The EUROPEAN ACADEMY FOR BIOMEDICAL SCIENCE (ENABLE) is an initiative funded by the European Union Horizon 2020 program involving four renowned European research institutes (Institute for Research in Biomedicine-IRB Barcelona, Spain; Radboud Institute for Molecular Life Sciences-RIMLS, the Netherlands; Novo Nordisk Foundation Center for Protein Research-NNF CPR, Denmark; European School of Molecular Medicine-SEMM, Italy) and an innovative science communication agency (Scienseed). With the aim to promote biomedical science of excellence in Europe, ENABLE organizes an annual three-day international event. This gathering includes a top-level scientific symposium bringing together leading scientists, PhD students, and post-doctoral fellows; career development activities supporting the progression of young researchers and fostering discussion about opportunities beyond the bench; outreach activities stimulating the interaction between science and society. The first European PhD and Postdoc Symposium, entitled "Breaking Down Complexity: Innovative models and techniques in biomedicine", was hosted by the vibrant city of Barcelona. The scientific program of the conference was focused on the most recent advances and applications of modern techniques and models in biomedical research and covered a wide range of topics, from synthetic biology to translational medicine. Overall, the event was a great success, with more than 200 attendees from all over Europe actively participating in the symposium by presenting their research and exchanging ideas with their peers and world-renowned scientists.

AB - The EUROPEAN ACADEMY FOR BIOMEDICAL SCIENCE (ENABLE) is an initiative funded by the European Union Horizon 2020 program involving four renowned European research institutes (Institute for Research in Biomedicine-IRB Barcelona, Spain; Radboud Institute for Molecular Life Sciences-RIMLS, the Netherlands; Novo Nordisk Foundation Center for Protein Research-NNF CPR, Denmark; European School of Molecular Medicine-SEMM, Italy) and an innovative science communication agency (Scienseed). With the aim to promote biomedical science of excellence in Europe, ENABLE organizes an annual three-day international event. This gathering includes a top-level scientific symposium bringing together leading scientists, PhD students, and post-doctoral fellows; career development activities supporting the progression of young researchers and fostering discussion about opportunities beyond the bench; outreach activities stimulating the interaction between science and society. The first European PhD and Postdoc Symposium, entitled "Breaking Down Complexity: Innovative models and techniques in biomedicine", was hosted by the vibrant city of Barcelona. The scientific program of the conference was focused on the most recent advances and applications of modern techniques and models in biomedical research and covered a wide range of topics, from synthetic biology to translational medicine. Overall, the event was a great success, with more than 200 attendees from all over Europe actively participating in the symposium by presenting their research and exchanging ideas with their peers and world-renowned scientists.

KW - Biomedicine

KW - Cancer

KW - Diabetes

KW - Leukemia

KW - Stem cells

KW - Symposium

U2 - 10.3390/jpm8020020

DO - 10.3390/jpm8020020

M3 - Conference article

C2 - 29786664

VL - 8

SP - 1

EP - 5

JO - Journal of Personalized Medicine

JF - Journal of Personalized Medicine

SN - 2075-4426

IS - 2

M1 - 20

Y2 - 15 November 2017 through 17 November 2017

ER -

ID: 198265208